Obermatt
See Similar Stocks →

Flags

Financial distress

Guardant Health

NSQ:GH · US40131M1099
Health Care Providers & ServicesLarge

360

14
Profit price89
Owner Earnings Yield1
Dividend Yield1
Price/Sales5
EV / Gross Profit1
Price/Book97
Return on Capital1
Cash Return on Capital1
EBIT Margin1
Gross Profitability69
Accruals43
Owner Earnings Margin4
Sales growth89
Profit growth11
Reinvestment34
Price momentum92
Debt load1
Refinancing39
Debt Payback1
Liquidity9
Analyst ratings74
Opinion Changes48
Price Target Upside30
Market mood73
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Guardant Health clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustryHealth Care Providers & Services
SizeLarge
TypePublic Company
ExchangeNASDAQGS
Founded2011
Employees2,426
Websiteguardanthealth.com
ISINUS40131M1099
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)D.J. US Health Care
Themes
Machine LearningArtificial IntelligenceGeneticsOncologyHealth DiagnosticsBiotechnologyHealth Care

Description

Guardant Health, Inc. is a precision oncology company. The company is transforming patient care by providing critical insights into what drives disease through the company’s advanced blood and tissue tests, real-world data and AI analytics. The comp…

Analysis

Weak and unloved

Guardant Health, Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is stretched. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
64
2023202420252026

All-time high

79

Jan 2025

All-time low

1

Jan 2023

Average rank

45

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
5
26
7
3
Price/Earnings
95
3
3
4
Price/Book
97
100
3
11
Dividend Yield
1
1
1
1
Value (overall)
63
65
6
10

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Guardant Health with its peers
Veracyte
NMQ:VCYT
80
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
GE Healthcare
NSQ:GEHC
32
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Biodesix
NMQ:BDSX
50
CountryUSA
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Iovance Biotherapeutics
NMQ:IOVA
56
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Labcorp
NYQ:LH
40
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Coherus Oncology
NMQ:CHRS
72
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →